Free Trial

1st week of landmark trial against opioid distributors ends

CHARLESTON, W.Va. (AP) — The West Virginia fire chief who starred in an Oscar-nominated documentary about battling drug abuse in ground zero of the nation’s opioid epidemic took the stand in a landmark trial Friday against three large drug distributors.

Huntington Fire Chief Jan Rader testified to the growing number of overdoses first responders handled over the past decade, recounting how pill bottles were at the scenes of so many calls they responded to. Defense attorneys representing the companies declined to ask her questions, The Herald-Dispatch reported.

Rader's testimony concluded the first week of the trial in a case where Cabell County and the city of Huntington accuse drug distributors AmerisourceBergen Drug Co., Cardinal Health Inc. and McKesson Corp of fueling the U.S. opioid epidemic.

Similar lawsuits have resulted in multimillion-dollar settlements, but this is the first time the allegations have wound up at federal trial. The result could have huge effects on hundreds of similar lawsuits that have been filed across the country.

The county and city argue that “The Big Three” drug distributors created a “public nuisance” by flooding the area with 80 million opioid doses over eight years and ignoring the signs that the community was being ravaged by addiction.

During the trial, attorneys for the manufacturers have attempted to shift the blame away from their clients by arguing that what happens after delivery is out of the suppliers’ control, and that West Virginia’s labor-intensive mining and industrial sectors may have led to workers with a greater need for painkillers. They also pointed out that the companies had no authority over illicit street drugs, the cause of the current crisis.

Attorneys for the plaintiffs expect to call several more witnesses next week, and the trial may last into mid-June.

Rader’s emergency response to drug overdoses was featured in the 2017 film “Heroin(e),” which also included a Cabell County judge and a ministry leader. It was released by Netflix and nominated for the Academy Award for best documentary short subject.

“This day has been a long time coming,” Rader said after leaving the federal courthouse in Charleston, according to The Herald-Dispatch. “This day is for all those suffering from substance use disorder who have lost their lives or have lost a loved one from this horrible disease.”

Huntington was once ground zero for the addiction epidemic until a quick response program that formed in 2017 drove the overdose rate down. But the pandemic undid much of the progress.

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
McKesson (MCK)
4.7237 of 5 stars
$725.90-0.9%0.39%28.10Moderate Buy$696.42
Cardinal Health (CAH)
4.8104 of 5 stars
$164.09-2.3%1.23%25.60Moderate Buy$157.43
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines